Analysts cut earnings per share estimates for Bank of N.T. Butterfield & Son, indicating potential business challenges. The bank's revenues are projected to underperform the broader industry. The consensus price target remains at US$35.20.
Bank of N.T. Butterfield & Son's moderate payout ratio and substantial EPS growth are favorable for its dividend payments. Considering these promising aspects, the firm could be drawing more attention from dividend-focused investors.
畢達菲爾特銀行股票討論區
加載中...
加載中...
新增數據:23Q4,營收萎縮2.4%,主要是淨利息收入減少造成的,疊加非利息費用增長,稅前利潤萎縮了17.4%,稅後萎縮15.2%。
2023年營收增長5.33%,淨利潤增長5.4%。
負債表顯示近兩年客戶存款一直在下降,從2021年的138.7億下降近20億到119.87億,這不是好跡象,而資產端基本都是長期貸款和投資,現金和短期投資只有47億,流動性不好,容易出擠兌問題。
目前市盈率6.55,股息率5.9%,估值還不算高,繼續觀察。
In reaction to earnings/guidance:
$Liberty Energy(LBRT.US)$ +11.6%, $F5 Inc(FFIV.US)$ +6.9%, $Encore纜線(WIRE.US)$ + 5.6%, $Archer Daniels Midland(ADM.US)$ +5.5%, $畢達菲爾特銀行(NTB.US)$ +5%, $奧爾巴尼國際(AIN.US)$ +5%, $3M(MMM.US)$ +4.0%,
Other news:
$Shell Midstream(SHLX.US)$ +10% (Shell USA to acquire all units in SHLX held by public at $15.85/unit total value $1.96 bln)
$BridgeBio Pharma(BBIO.US)$...
暫無評論